NINGBO INNO PHARMCHEM CO.,LTD. is at the forefront of supplying critical chemical intermediates, and 4-Isothiocyanato-2-(trifluoromethyl)benzonitrile (CAS 143782-23-4) plays an indispensable role in the pharmaceutical landscape, particularly in the synthesis of Enzalutamide.

Enzalutamide is a potent anti-androgen medication used to treat prostate cancer. Its complex molecular structure is meticulously assembled through a series of precise chemical reactions, with 4-Isothiocyanato-2-(trifluoromethyl)benzonitrile serving as a foundational building block. The specific arrangement of the trifluoromethyl group and the isothiocyanate moiety on the benzonitrile ring is crucial for the subsequent cyclization and formation of the active pharmaceutical ingredient.

The 4-isothiocyanato-2-(trifluoromethyl)benzonitrile synthesis often involves controlled reactions to ensure the correct stereochemistry and purity, which are paramount in pharmaceutical chemistry. Understanding the 4-isothiocyanato-2-(trifluoromethyl)benzonitrile chemical properties, such as its reactivity with amines and other nucleophiles, is key to optimizing the Enzalutamide production process. Researchers constantly seek efficient ways to incorporate this intermediate, driving demand for its reliable supply.

The market for such specialized intermediates is highly competitive, with manufacturers keenly interested in the enzalutamide intermediate price and the quality offered by various suppliers. As a key player, NINGBO INNO PHARMCHEM CO.,LTD. ensures that its provision of high-purity 4-Isothiocyanato-2-(trifluoromethyl)benzonitrile supports the consistent production of life-saving medications. The ongoing research into new 4-isothiocyanato-2-(trifluoromethyl)benzonitrile uses further highlights its significance in the pharmaceutical industry.